GLP-1 (glucagon-like peptide-1) medications such as Ozempic, Wegovy, and Mounjaro are becoming increasingly popular for medical weight loss
Pour en bnficier, il est recommand de se renseigner auprs de son mdecin ou pharmacien
EoE is mentioned in this episode
Tanimizu, N., Ichinohe, N
However, it also produces some direct and indirect side effects
More serious but less common adverse effects observed in trials or associated with this drug class include: Increased heart rate , a class effect seen with GLP-1 receptor agonists [15] [12] Gallbladder disease , including gallstones (cholelithiasis), which has been associated with rapid weight loss and incretin-based therapies more broadly